Showing results (41-50 of 124) with videos related to
Sort By:
Pageof 13
Cancer|February 1, 1995
Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancerL A Solé, J Albanell, J Bellmunt, et al.Revista Clinica Espanola|May 1, 1992
[Bladder neoplasm in a patient with panarteritis nodosa treated with cyclophosphamide]J Albanell, O S Gallego, J Bellmunt, et al.Tumori|December 31, 1990
Addison's disease secondary to prostatic carcinoma. A case reportM Navarro, E Felip, L Garcia, et al.Oncology|January 1, 1989
Mitomycin-C and vinblastine in advanced breast cancerM Navarro, J Bellmunt, C Balañá, et al.Life Sciences|January 1, 1997
Urinary pyrraline as a biochemical marker of non-oxidative Maillard reactions in vivoM Portero-Otín, R Pamplona, M J Bellmunt, et al.Tumori|August 31, 1992
Endobronchial metastases in colorectal adenocarcinomaA Rovirosa Casino, J Bellmunt, A Salud, et al.Diabetes|October 27, 1999
Diabetes induces an impairment in the proteolytic activity against oxidized proteins and a heterogeneous effect in nonenzymatic protein modifications in the cytosol of rat liver and kidneyM Portero-Otín, R Pamplona, M C Ruiz, et al.Revista Clinica Espanola|October 1, 1991
[Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung]M Navarro, E Mur, L Jolis, et al.European Journal of Biochemistry|September 17, 1998
Carboxymethylated phosphatidylethanolamine in mitochondrial membranes of mammals--evidence for intracellular lipid glycoxidationR Pamplona, J R Requena, M Portero-Otín, et al.Journal of Lipid Research|October 27, 1998
Mitochondrial membrane peroxidizability index is inversely related to maximum life span in mammalsR Pamplona, M Portero-Otín, D Riba, et al.Pageof 13